Where is Ascendis Pharma headquartered?

Ascendis Pharma is located in Hellerup, other.

Who invested in Ascendis Pharma?

Ascendis Pharma has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Ascendis Pharma raised to date?

Ascendis Pharma has raised ____.

When was the last funding round for Ascendis Pharma?

Ascendis Pharma closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

ascendispharma.com

Ascendis Pharma

Ascendis Pharma develops drugs for endocrinology, central nervous system disorders and infectious diseases.

Business Model:

Revenue: $4.7M

Employees: 201-500

Geographic Data

Address: Tuborg Boulevard 5

City: Hellerup

State: other

Zip: 2900

Country: DK

Financial Info

Stage:

post ipo debt

Raised Last:

$500M

Raised Total:

$217M

Social

Crunchbase

Metrics

2,000,048Website Global Rank

10,414Website Monthly Traffic

Twitter Followers

Description

Ascendis Pharma develops drugs for endocrinology, central nervous system disorders and infectious diseases.

Contact Phone:

Contact Email:

IPO Details

Ascendis Pharma went public on 1/28/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
1/28/2015

IPO Valuation:
$373M

Ticker Symbol:
ASND

IPO Price:
$18/share

Amount Raised:
$108M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction
11/2018	Visen Pharmaceuticals	Series A
1/2021	Visen Pharmaceuticals	Series B
1/2021	Visen Pharmaceuticals	Series B
11/2018	Visen Pharmaceuticals	Series A

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2014	IPO		$108M
3/2022	Post-IPO Debt		$500M
1/2017	Post-IPO Equity	1	-	Sofinnova Investments Sofinnova Investments
12/2007	Series A	3	$25.7M	Gilde Healthcare TechnoStart Sofinnova Partners Gilde Healthcare Sofinnova Partners Gilde Healthcare TechnoStart Sofinnova Partners Gilde Healthcare Sofinnova Partners
12/2014	Series D	6	$60M	Venrock Sofinnova Investments Rock Springs Capital RA Capital Management OrbiMed Vivo Capital OrbiMed Sofinnova Investments Vivo Capital Venrock Sofinnova Investments Rock Springs Capital RA Capital Management OrbiMed Vivo Capital OrbiMed Sofinnova Investments Vivo Capital
11/2014	Series D		$60M	Sofinnova Ventures OrbiMed Vivo Capital Janus Capital Management Venrock RA Capital Management Rock Springs Capital Sectoral Asset Management
6/2010	Unattributed		$22.9M	Sofinnova Ventures Gilde Healthcare Partners Zweite TechnoStart Ventures Fonds GmbH
12/2007	Series A		$25.8M	Sofinnova Partners SAS Gilde Healthcare Partners
1/2017	Post-IPO Equity	1	-	Sofinnova Investments Sofinnova Investments

Acquisitions

Announced Date	Name	Price
12/2007	Complex Biosystems

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details